Liu J, Hu M, Chen J, Zu X, et al. Tro-score, a trogocytosis-related transcriptomic signature, identifies CD109 as a therapeutic target for reversing immunosuppression in bladder cancer. Int Immunopharmacol 2026;187:117273.
PMID: 42580141